pipette
ESEspañol

Spatial and single-nucleus transcriptomics reveals the molecular pathology of type 2 diabetes–associated cognitive dysfunction

Wei Wu, Yumeng Yang, Xixi Zhang, Baojian Liao, Siyu Kong, Bingbing Xie, Yanping Lu, Mingyue Jiang, Xiu Liang, Lei Zhang, Meiyi Zhou, Xiaojing Zhang, Ning‐Yi Shao, Gholson J. Lyon, Yaqing Shu, Shengbao Suo, Ning Ma

Peer-reviewed journal

In the authors' words

The mechanisms underlying type 2 diabetes–associated cognitive dysfunction (DACD) remain poorly understood, hindering therapeutic progress. Here, we integrated spatial transcriptomics and single-nucleus RNA sequencing to delineate the spatiotemporal molecular and cellular landscape of DACD in brain tissues from 3- and 6-mo-old mouse models. Our findings revealed region- and cell-type-specific transcriptomic alterations, with excitatory neurons in the hippocampus and isocortex emerging as the most severely affected populations with pronounced synaptic dysfunction. Further analysis of these two regions identified disease-associated transcription factors, such as Rfx3 and Mef2c . In parallel, we uncovered multiple ligand–receptor pairs, including Hsp90b1 – Lrp6 and S100a1 – Ryr2 , whose downstream signaling networks converged on lactate dehydrogenase B ( Ldhb ) as a shared effector, thereby prompting functional validation. Notably, brain-wide and excitatory neuron-specific Ldhb overexpression alleviated DACD-induced mitochondrial dysfunction, oxidative stress, neuronal apoptosis, and cognitive impairment. Collectively, our study delineates the spatiotemporal transcriptomic landscape of DACD, offers a valuable resource for mechanistic exploration, and highlights Ldhb as a potential therapeutic target in DACD.

Main resultThe abstract does not state a limitation.

Appeared: Thursday, October 8. Proceedings of the National Academy of Sciences. Peer-reviewed journal.

DOI: 10.1073/pnas.2529793123